WED-196 Analyses of fibrosis biomarkers PRO-C3 and ELF in resmetirom treated patients from MAESTRO-NASH, a 52 Week NASH/MASH serial liver biopsy study von Anstee, Quentin M., Schattenberg, Jörn M, Taub, Rebecca, Labriola, Dominic, Zhang, Hang, Hennan, Jim

Volltext

Utility of FIB-4 thresholds to identify patients with at-risk F2-F3 NASH based on screening data from a 2000 patient biopsy confirmed cohort of resmetirom Phase 3 clinical trial, M... von Schattenberg, Jörn, Alkhouri, Naim, Taub, Rebecca, Hennan, Jim, Noureddin, Mazen, Harrison, Stephen

Volltext

Retrospective AI-based measurement of NASH histology (AIM-NASH) analysis of biopsies from Phase 2 study of Resmetirom confirms significant treatment-induced changes in histologic f... von Harrison, Stephen, Iyer, Janani, Biddle-Snead, Charles, Hoffman, Sara, Le, Quang, Mountain, Victoria, Resnick, Murray, Wack, Katy, Hennan, Jim, Taub, Rebecca

Volltext

Characterizing the histologic implications of resmetirom-induced liver volume reduction using artificial intelligence-powered digital pathology von Mistry, Pratik, Stanford-Moore, Adam, Egger, Robert, Glickman, Jonathan, Baker, Brian, Chandra, Nidhi, Juyal, Dinkar, Khosla, Archit, Drage, Michael, Resnick, Murray, Wack, Katy, Hennan, Jim, Loomba, Rohit, Harrison, Stephen, Taub, Rebecca, Iyer, Janani

Volltext

WED-522 - Characterizing the histologic implications of resmetirom-induced liver volume reduction using artificial intelligence-powered digital pathology von Mistry, Pratik, Stanford-Moore, Adam, Egger, Robert, Glickman, Jonathan, Baker, Brian, Chandra, Nidhi, Juyal, Dinkar, Khosla, Archit, Drage, Michael, Resnick, Murray, Wack, Katy, Hennan, Jim, Loomba, Rohit, Harrison, Stephen, Taub, Rebecca, Iyer, Janani

Volltext